Remote monitoring for ATTR-CM patients
Part of Heart & circulation clinical trials.
This trial tests a smartphone app that lets you track symptoms and share them with your care team between visits. The goal is to see if remote monitoring is practical and helpful for people with ATTR-CM.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have been diagnosed with ATTR-CM.
- You are taking a medication for ATTR-CM, or you are just starting one at your next visit.
- You have a smartphone and know how to use it, and you have internet.
- You are not taking part in another clinical trial at the same time.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This registry collects information from people with ATTR-CM, a condition where abnormal protein builds up in the heart. By joining, you help researchers learn more about the disease and improve future care.
This trial tests a new medicine called Coramitug for people with heart failure due to ATTR amyloidosis, a condition where abnormal proteins build up in the heart. The study aims to see if Coramitug can improve heart function and quality of life.
This trial tests an eHealth support system designed to help people with ATTR amyloidosis (a type of heart disease) who have had a recent heart failure episode. It aims to improve care and follow-up for people with this condition.
This trial tests whether using home weight/health tracking can help people with ATTR cardiomyopathy avoid going to the hospital. It may help by catching fluid build-up or worsening earlier so treatment can be adjusted sooner.
This trial uses heart scans to see how the drug acoramidis affects heart structure and function in people with a specific type of heart disease called ATTR cardiomyopathy. It may help doctors understand if the treatment is working.
This trial tests whether a smartphone app can help monitor your heart health after a hospital stay for heart failure. It is for people who use a smartphone often and have a type of heart failure where the heart's pumping strength is lower than normal.
Hear when a new Transthyretin Amyloid Cardiomyopathy (ATTR-CM) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.